By Patrick Wingrove and Ahmed Aboulenein (Reuters) -Eli Lilly plans to spend at least $27 billion to build four new ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Hugely popular weight loss drugs known as GLP-1's are finally getting cheaper, well at least one is, and that's the case with ...
Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range ...
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
The pharma group has just announced that it will build four new manufacturing facilities in the US – at a cost of around $27 ...